Ventral Mesh Hernioplasty : Laparoscopic Versus Open Sublay
Launched by ASSIUT UNIVERSITY · Nov 26, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating two different methods for repairing ventral hernias, which are bulges that can occur in the abdominal wall. The two techniques being compared are laparoscopic repair, which is done using small incisions and special instruments, and open sublay repair, which involves a larger incision. The study aims to find out which method results in fewer complications, less pain after surgery, and lower chances of the hernia coming back.
To participate in this trial, individuals must be between the ages of 18 and 75 and have a midline ventral hernia that is suitable for surgery. However, those who are not healthy enough for surgery, have complicated hernias, or have previous hernia repairs may not be eligible. Participants can expect to be monitored closely throughout the trial to assess their recovery, and the study is not yet recruiting, meaning it will start in the future. This research is important as it could help doctors choose the best surgical approach for treating ventral hernias.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All cases of midline ventral hernia fit for surgery
- Exclusion Criteria:
- • 1. Surgically unfit cases
- • 2. Complicated hernia (obstructed ,irreducible, strangulated)
- • 3. incisional ,massive ,recurrent hernias
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
hisham ryad
Study Director
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported